These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12653815)

  • 21. Naltrexone shortened opioid detoxification with buprenorphine.
    Umbricht A; Montoya ID; Hoover DR; Demuth KL; Chiang CT; Preston KL
    Drug Alcohol Depend; 1999 Oct; 56(3):181-90. PubMed ID: 10529020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved?
    Caldiero RM; Parran TV; Adelman CL; Piche B
    Am J Addict; 2006; 15(1):1-7. PubMed ID: 16449087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial.
    Raistrick D; West D; Finnegan O; Thistlethwaite G; Brearley R; Banbery J
    Addiction; 2005 Dec; 100(12):1860-7. PubMed ID: 16367987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.
    D'Onofrio G; O'Connor PG; Pantalon MV; Chawarski MC; Busch SH; Owens PH; Bernstein SL; Fiellin DA
    JAMA; 2015 Apr; 313(16):1636-44. PubMed ID: 25919527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Baltimore Buprenorphine Initiative: understanding the role of buprenorphine in addressing heroin addiction in an urban-based community.
    Murphy LS; Oros MT; Dorsey SG
    J Addict Nurs; 2014; 25(1):16-25; quiz 26-7. PubMed ID: 24613946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Buprenorphine maintenance treatment of heroin dependence: the first experience from Iran.
    Ahmadi J
    J Subst Abuse Treat; 2002 Apr; 22(3):157-9. PubMed ID: 12039619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brief vs. extended buprenorphine detoxification in a community treatment program: engagement and short-term outcomes.
    Katz EC; Schwartz RP; King S; Highfield DA; O'Grady KE; Billings T; Gandhi D; Weintraub E; Glovinsky D; Barksdale W; Brown BS
    Am J Drug Alcohol Abuse; 2009; 35(2):63-7. PubMed ID: 19199166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
    Harris AH; Gospodarevskaya E; Ritter AJ
    Pharmacoeconomics; 2005; 23(1):77-91. PubMed ID: 15693730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of buprenorphine treatment for opioid dependence.
    Johnson RE; Jaffe JH; Fudala PJ
    JAMA; 1992 May; 267(20):2750-5. PubMed ID: 1578593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience.
    Amass L; Ling W; Freese TE; Reiber C; Annon JJ; Cohen AJ; McCarty D; Reid MS; Brown LS; Clark C; Ziedonis DM; Krejci J; Stine S; Winhusen T; Brigham G; Babcock D; Muir JA; Buchan BJ; Horton T
    Am J Addict; 2004; 13 Suppl 1(Suppl 1):S42-66. PubMed ID: 15204675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time-limited buprenorphine replacement therapy for opioid dependence: 2-year follow-up outcomes in relation to programme completion and current agonist therapy status.
    Kornør H; Waal H; Sandvik L
    Drug Alcohol Rev; 2007 Mar; 26(2):135-41. PubMed ID: 17364848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid heroin detoxification using a single high dose of buprenorphine.
    Kutz I; Reznik V
    J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.
    Hser YI; Evans E; Huang D; Weiss R; Saxon A; Carroll KM; Woody G; Liu D; Wakim P; Matthews AG; Hatch-Maillette M; Jelstrom E; Wiest K; McLaughlin P; Ling W
    Addiction; 2016 Apr; 111(4):695-705. PubMed ID: 26599131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study.
    Marsden J; Eastwood B; Bradbury C; Dale-Perera A; Farrell M; Hammond P; Knight J; Randhawa K; Wright C;
    Lancet; 2009 Oct; 374(9697):1262-70. PubMed ID: 19800681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
    Strain EC; Stitzer ML; Liebson IA; Bigelow GE
    J Clin Psychopharmacol; 1996 Feb; 16(1):58-67. PubMed ID: 8834420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: results of a multicenter study of 73 patients.
    Poirier MF; Laqueille X; Jalfre V; Willard D; Bourdel MC; Fermanian J; Olié JP
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):267-72. PubMed ID: 14751421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of substitution therapy on the birth weight of the newborn, its postpartum adaptation, trophic and course of the neonatal abstinence syndrome].
    Vavrinková B; Binder T
    Ceska Gynekol; 2007 Aug; 72(4):247-53. PubMed ID: 17966605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.